| Net Cash Provided by (Used in) Operating Activities |
1.01B |
USD |
+1346% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
14.3B |
USD |
-22.2% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
-16.9B |
USD |
-3.07% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
90B |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
580M |
shares |
+2.58% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-1.6B |
USD |
-179% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
21.2B |
USD |
+20.3% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
321M |
USD |
+92.2% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
75M |
USD |
+127% |
Q4 2024 |
FY 2024 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
5.28B |
USD |
-49.6% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Issued |
28.7M |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Unrecognized Tax Benefits |
10M |
USD |
-47.4% |
Q4 2024 |
FY 2024 |
| Additional Paid in Capital |
16.9B |
USD |
+12.3% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
28.7M |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Depreciation, Depletion and Amortization |
308M |
USD |
+29.4% |
Q1 2025 |
Q1 2025 |
| Share-based Payment Arrangement, Expense |
766M |
USD |
-27.5% |
Q3 2025 |
Q3 2025 |